NO166284C - Fremgangsmaate for fremstilling av en stoffblanding som ereffektiv til lokalisering og/eller oedeleggelse av tumorer. - Google Patents

Fremgangsmaate for fremstilling av en stoffblanding som ereffektiv til lokalisering og/eller oedeleggelse av tumorer.

Info

Publication number
NO166284C
NO166284C NO84842089A NO842089A NO166284C NO 166284 C NO166284 C NO 166284C NO 84842089 A NO84842089 A NO 84842089A NO 842089 A NO842089 A NO 842089A NO 166284 C NO166284 C NO 166284C
Authority
NO
Norway
Prior art keywords
tumors
molecular weight
localization
substance
destruction
Prior art date
Application number
NO84842089A
Other languages
English (en)
Norwegian (no)
Other versions
NO842089L (no
NO166284B (no
Inventor
Kenneth R Weishaupt
Thomas J Dougherty
William R Potter
Original Assignee
Photofrin Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photofrin Medical Inc filed Critical Photofrin Medical Inc
Publication of NO842089L publication Critical patent/NO842089L/no
Publication of NO166284B publication Critical patent/NO166284B/no
Publication of NO166284C publication Critical patent/NO166284C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO84842089A 1982-09-27 1984-05-25 Fremgangsmaate for fremstilling av en stoffblanding som ereffektiv til lokalisering og/eller oedeleggelse av tumorer. NO166284C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42464782A 1982-09-27 1982-09-27
US48134583A 1983-04-01 1983-04-01
PCT/US1983/001379 WO1984001382A1 (en) 1982-09-27 1983-09-09 Purified hematoporphyrin derivative for diagnosis and treatment of tumors, and method

Publications (3)

Publication Number Publication Date
NO842089L NO842089L (no) 1984-05-25
NO166284B NO166284B (no) 1991-03-18
NO166284C true NO166284C (no) 1991-06-26

Family

ID=27026406

Family Applications (1)

Application Number Title Priority Date Filing Date
NO84842089A NO166284C (no) 1982-09-27 1984-05-25 Fremgangsmaate for fremstilling av en stoffblanding som ereffektiv til lokalisering og/eller oedeleggelse av tumorer.

Country Status (10)

Country Link
EP (1) EP0120054B1 (de)
JP (1) JPS60500132A (de)
AT (1) ATE53204T1 (de)
AU (1) AU581840B2 (de)
CA (1) CA1271746A (de)
DE (1) DE3381616D1 (de)
DK (1) DK172284B1 (de)
NL (1) NL940021I2 (de)
NO (1) NO166284C (de)
WO (1) WO1984001382A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4693885A (en) * 1984-07-18 1987-09-15 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US5104637A (en) * 1985-02-06 1992-04-14 University Of Cincinnati Radio labeled dihematophorphyrin ether and its use in detecting and treating neoplastic tissue
US5066274A (en) * 1985-04-30 1991-11-19 Nippon Petrochemicals Company, Ltd. Tetrapyrrole therapeutic agents
US4977177A (en) * 1985-04-30 1990-12-11 Nippon Petrochemicals Company, Ltd. Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents
EP0210351B1 (de) * 1985-04-30 1993-07-21 Nippon Petrochemicals Co., Ltd. Verwendung von Porphyrinderivaten bei der Entdeckung und Behandlung von Tumoren
US4656186A (en) * 1985-04-30 1987-04-07 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
GB8522670D0 (en) * 1985-09-13 1985-10-16 Efamol Ltd Drug treatments
AU603999B2 (en) * 1985-10-23 1990-12-06 Photochemical Co., Ltd. Porphyrin derivatives, and their production and use
US5051415A (en) * 1986-01-02 1991-09-24 The University Of Toledo Production and use of purpurins, chlorins and purpurin- and chlorin-containing compositions
EP0256036B1 (de) * 1986-01-02 1993-04-07 The University Of Toledo Herstellung und verwendung von purpurinen, chlorinen und purpurin und chlorin enthaltenden zubereitungen
US5216012A (en) * 1986-01-02 1993-06-01 University Of Toledo Production and use of purpurins, chlorins and purpurin- and chlorin-containing compositions
US5534506A (en) * 1986-01-02 1996-07-09 University Of Toledo Use of purpurins, chlorins and purpurin- and chlorin-containing compositions
US4882234A (en) * 1986-11-12 1989-11-21 Healux, Inc. Storage-stable porphin compositions and a method for their manufacture
US4920143A (en) * 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US5171749A (en) * 1987-01-20 1992-12-15 University Of British Columbia Wavelength-specific cytotoxic agents
US5283255A (en) * 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents
US4925736A (en) * 1988-07-06 1990-05-15 Long Island Jewish Medical Center Topical hematoporphyrin
USRE38994E1 (en) 1988-07-20 2006-02-28 Health Research, Inc. Pyropheophorbides conjugates and their use in photodynamic therapy
USRE39094E1 (en) 1988-07-20 2006-05-09 Health Research, Inc. Pyropheophorbides and their use in photodynamic therapy
GB2254417A (en) * 1991-04-05 1992-10-07 Bijan Jouza Photodynamic laser detection for cancer diagnosis
NL9200143A (nl) * 1992-01-27 1993-08-16 Seehof Lab F & E Ges Werkwijze voor de bereiding van een actief middel te gebruiken voor de fotodynamische therapie en voor het vaststellen van een diagnose, therapeutisch middel en diagnosticum dat het actief middel bevat en farmaceutische samenstelling.
RU2128993C1 (ru) * 1996-03-27 1999-04-20 Московская государственная академия тонкой химической технологии им.М.В.Ломоносова Фармакологическое средство фотогем для фотодинамической терапии рака
US5948061A (en) 1996-10-29 1999-09-07 Double Click, Inc. Method of delivery, targeting, and measuring advertising over networks
US7039599B2 (en) 1997-06-16 2006-05-02 Doubleclick Inc. Method and apparatus for automatic placement of advertising
JP5053483B2 (ja) 1998-08-03 2012-10-17 グーグル インコーポレイティド 再ターゲット化広告配布のためのネットワーク
US7166719B2 (en) 2002-06-27 2007-01-23 Health Research, Inc. Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy
US7897140B2 (en) 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
US6624187B1 (en) 2000-06-12 2003-09-23 Health Research, Inc. Long wave length absorbing bacteriochlorin alkyl ether analogs
AU2003249742A1 (en) 2002-07-02 2004-01-23 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives

Also Published As

Publication number Publication date
AU2032283A (en) 1984-04-24
NL940021I1 (nl) 1997-03-03
CA1271746A (en) 1990-07-17
AU581840B2 (en) 1989-03-09
ATE53204T1 (de) 1990-06-15
NO842089L (no) 1984-05-25
EP0120054A1 (de) 1984-10-03
NO166284B (no) 1991-03-18
WO1984001382A1 (en) 1984-04-12
EP0120054A4 (de) 1985-04-11
DE3381616D1 (de) 1990-07-05
EP0120054B1 (de) 1990-05-30
JPS60500132A (ja) 1985-01-31
DK261384A (da) 1984-05-25
NL940021I2 (nl) 1997-05-01
DK261384D0 (da) 1984-05-25
DK172284B1 (da) 1998-02-23

Similar Documents

Publication Publication Date Title
NO166284C (no) Fremgangsmaate for fremstilling av en stoffblanding som ereffektiv til lokalisering og/eller oedeleggelse av tumorer.
EP0127471B1 (de) Phosphorsäurediester, Salze davon, diese enthaltende Zusammensetzungen und Verfahren zur Herstellung solcher Diester und Salze
ES8703881A1 (es) Procedimiento para la fabricacion de derivados del acido &- (oxo-2 hexahidro-2,4,5,6,7,7a tieno (3,2-c)piridil-5) fenil acetico
PT88944A (pt) Processo para a preparacao de novos derivados de benzociclohepteno e de composicoes farmaceuticas que os contem
Schilling et al. Isolation, Structure and Synthesis of a Lathyrus Factor From L. Odoratus1, 2
ATE25246T1 (de) Triphenylimidazolyloxyalkansaeuren und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
CH676715A5 (de)
ZA832044B (en) Imidazolyphenyl-tetrahydropyridazines,processes for their preparation and pharmaceutical preparation containing them
PT76279A (en) Process for the preparation of novel crystal modifications of (+)-catechin
AU611113B2 (en) Basically substituted phenylacetonitriles, their preparation and drugs containing these compounds
DE2730549A1 (de) Peptidderivate und deren herstellung
ATE4169T1 (de) Antacidum auf der basis von magnesium-aluminium- hydroxyd und seine herstellung.
PT80791A (fr) Procede de preparation de nouvelles phenyl-naphtiridines utiles notamment comme medicaments anti-ulceres
ES8802612A1 (es) Procedimiento para preparar derivados de benzisoselenazolilo
ES2037003T3 (es) Procedimiento para preparar peptidos empleando percloratos.
EP0207483A3 (en) Benzimidazoles, process for their preparation, medicaments containing them and intermediates
IT1163772B (it) Oligosaccaridi eterogenei complessabili ed alfa-idosani ad attivita' terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche
WO1986000621A1 (fr) Hexapeptide
SU814860A1 (ru) Способ получени модифицированногодиСпЕРСНОгО КРЕМНЕзЕМА
JPS5795918A (en) Purification of immunoglobulin
RU2148583C1 (ru) 3-О-2-ДЕЗОКСИ-α-D-ГАЛАКТО- ИЛИ α-L-РАМНОПИРАНОЗИД МЕТИЛОВОГО ЭФИРА ГЛИЦИРРЕТОВОЙ КИСЛОТЫ, ПРОЯВЛЯЮЩИЙ ПРОТИВОЯЗВЕННУЮ АКТИВНОСТЬ И СТИМУЛИРУЮЩИЙ РЕПАРАТИВНУЮ РЕГЕНЕРАЦИЮ КОЖИ
DK632187D0 (da) Ny forbedret fremgangsmaade til fremstilling af penicillansyrederivater
EP0192317A1 (de) Homocarnosin- oder Acylhomocarnosin-Salze
ES2116398T3 (es) Derivados de la porfirina, para diagnosis y terapia fotodinamica.
BG50095A1 (en) Esters of 1- methyl- 10 alpha- metoxy- 9, 10- dihydro- lisergol and method for their preparation

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN SEPTEMBER 2003